Concepedia

Michele W.L. Teng

MW

77

Publications

11.2K

Citations

53

H-Index

2002

Active since

Affiliations

QIMR Berghofer Medical Research Institute(Current)

Peter MacCallum Cancer Centre

The University of Queensland

The University of Melbourne

Juntendo University

Michele W.L. Teng is an author at QIMR Berghofer Medical Research Institute specializing in medicine, immunology, and immunotherapy.

Top concepts

MedicineImmunologyImmunotherapyTumor ImmunityAutoimmunityCell BiologyTumor MicroenvironmentTumor BiologyCancer ResearchT Cell Immunity

Publications per year

2002–2022

77

Publications

77

Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease

Jing Liu, Stephen J. Blake, Michelle C.R. Yong et al. · Cancer Discovery · 2016 · 833 citations

Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells

Yulong Gao, Fernando Souza-Fonseca-Guimarães, Tobias Bald et al. · Nature Immunology · 2017 · 624 citations

Type 1, Cancer Immunosurveillance, Autoimmune Disease +12

Anti-TIM3 Antibody Promotes T Cell IFN-γ–Mediated Antitumor Immunity and Suppresses Established Tumors

Shin Foong Ngiow, Bianca von Scheidt, Hisaya Akiba et al. · Cancer Research · 2011 · 560 citations

TIGIT predominantly regulates the immune response via regulatory T cells

Sema Kurtuluş, Kaori Sakuishi, Shin-Foong Ngiow et al. · Journal of Clinical Investigation · 2015 · 534 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +20

Anti–ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti–PD-1 or anti-CD137 mAb therapy

John Stagg, Sherene Loi, Upulie Divisekera et al. · Proceedings of the National Academy of Sciences · 2011 · 476 citations

Rows per page

1–5 of 77